AU779462B2 - Selectable cell surface marker genes - Google Patents

Selectable cell surface marker genes Download PDF

Info

Publication number
AU779462B2
AU779462B2 AU25070/01A AU2507001A AU779462B2 AU 779462 B2 AU779462 B2 AU 779462B2 AU 25070/01 A AU25070/01 A AU 25070/01A AU 2507001 A AU2507001 A AU 2507001A AU 779462 B2 AU779462 B2 AU 779462B2
Authority
AU
Australia
Prior art keywords
cells
mutated
ptkr
musk
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25070/01A
Other languages
English (en)
Other versions
AU2507001A (en
Inventor
Susanne Dagmar Pippig
Gabor Veres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2507001A publication Critical patent/AU2507001A/en
Application granted granted Critical
Publication of AU779462B2 publication Critical patent/AU779462B2/en
Priority to AU2005201764A priority Critical patent/AU2005201764A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25070/01A 1999-11-19 2000-11-17 Selectable cell surface marker genes Ceased AU779462B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005201764A AU2005201764A1 (en) 1999-11-19 2005-04-27 Selectable cell surface marker genes

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US44403899A 1999-11-19 1999-11-19
US16659499P 1999-11-19 1999-11-19
US09/444038 1999-11-19
US60/166594 1999-11-19
US53924800A 2000-03-30 2000-03-30
US09/539248 2000-03-30
PCT/EP2000/011474 WO2001036659A2 (fr) 1999-11-19 2000-11-17 Genes marqueurs de surface selectionnables

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005201764A Division AU2005201764A1 (en) 1999-11-19 2005-04-27 Selectable cell surface marker genes

Publications (2)

Publication Number Publication Date
AU2507001A AU2507001A (en) 2001-05-30
AU779462B2 true AU779462B2 (en) 2005-01-27

Family

ID=27389294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25070/01A Ceased AU779462B2 (en) 1999-11-19 2000-11-17 Selectable cell surface marker genes

Country Status (7)

Country Link
EP (1) EP1278773A2 (fr)
JP (1) JP2003522525A (fr)
AU (1) AU779462B2 (fr)
CA (1) CA2391593A1 (fr)
IL (1) IL149621A0 (fr)
NZ (1) NZ518877A (fr)
WO (1) WO2001036659A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4362035B2 (ja) * 2001-05-11 2009-11-11 メディカル リサーチ カウンシル Ｒｈｏｍｂｏｉｄポリペプチドのモジュレーターを同定するアッセイ
EP1479693A4 (fr) * 2002-02-05 2005-07-27 Japan Science & Tech Agency Complexe egf/egfr
EP3527585B1 (fr) * 2009-11-03 2022-02-16 City of Hope Récepteur du facteur de croissance épidermique tronqué (egfrt) pour la sélection de lymphocytes t transduits

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1261847B (it) * 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
US6107477A (en) * 1996-09-26 2000-08-22 Aurora Biosciences Corporation Non-optimal Kozaks sequences

Also Published As

Publication number Publication date
IL149621A0 (en) 2002-11-10
AU2507001A (en) 2001-05-30
JP2003522525A (ja) 2003-07-29
NZ518877A (en) 2004-03-26
EP1278773A2 (fr) 2003-01-29
WO2001036659A3 (fr) 2002-11-14
CA2391593A1 (fr) 2001-05-25
WO2001036659A2 (fr) 2001-05-25

Similar Documents

Publication Publication Date Title
JP7320656B2 (ja) 形質導入Ｔ細胞選択のためのトランケート上皮増殖因子レセプタ（ＥＧＦＲｔ）
JP6684782B2 (ja) キメラ抗原受容体
US9650428B2 (en) Methods and compositions for treating cancer
US11242377B2 (en) Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains
KR20210019993A (ko) Τ 세포 수용체 및 이를 발현하는 조작된 세포
CN110785432A (zh) Tcr和肽
JP2018502583A (ja) 修飾された肝炎転写後調節エレメント
KR20210120019A (ko) 세포-특이적 전사 조절 서열 및 이의 용도
US6451558B1 (en) Genes in the control of hematopoiesis
US6790614B1 (en) Selectable cell surface marker genes
AU779462B2 (en) Selectable cell surface marker genes
CN111378046B (zh) 一种免疫效应细胞转换受体
US20020150876A1 (en) Selectable marker genes
AU2001273906B2 (en) Selectable marker genes
EP1148066B1 (fr) Utilisation de CD34 ou d'un polypeptide derivé comme marqueur de la surface cellulaire pour transfert genique
EP1100914A2 (fr) Nouveaux genes de regulation de l'hematopoiese
CN114729328A (zh) Tmem59蛋白二聚体或嵌合表达受体改善t细胞功能
AU2005201764A1 (en) Selectable cell surface marker genes
AU2001273906A1 (en) Selectable marker genes
WO2023286840A1 (fr) Antigène anti-ｅｇｆｒｖｉｉｉ, polypeptide, cellule exprimant ledit polypeptide, composition pharmaceutique contenant ladite cellule, procédé de fabrication de ladite cellule, et polynucléotide ou vecteur contenant une séquence des bases codant ledit polypeptide
KR20240035506A (ko) 키메라 항원 수용체, 상기 수용체를 발현하는 세포, 상기 세포를 포함하는 의약 조성물, 상기 세포의 제조 방법, 및 상기 키메라 항원 수용체를 코딩하는 염기서열을 포함하는 폴리뉴클레오티드 또는 벡터
WO2000075291A2 (fr) EXPRESSION FORCEE DE BCL-xL
CN116997654A (zh) 编码抗乙酰胆碱受体自身抗体的嵌合受体的基因